E Paul Wileyto

7PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 09, 2026
Feasibility and Acceptability of Automated Texts to Offer, Screen, and Enroll Patients in a Cancer Clinical Trial Financial Reimbursement Program: Mixed Methods Study.

|Apr 30, 2026
A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 glioma.

|Feb 13, 2025
A single-arm phase 2 study of abemaciclib in adult patients with recurrent grade 3 oligodendroglioma.

Carson A Wills, Suyash Mohan, Ali Nabavizadeh

|Oct 06, 2021
Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer.

Ravi B Parikh, Samuel U Takvorian, Daniel Vader

|Jan 21, 2021
The efficacy and safety of definitive concurrent chemoradiotherapy for non-operable esophageal cancer.

Alexandra D Dreyfuss, Andrew R Barsky, E Paul Wileyto

|Jul 21, 2020
Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV.

Rebecca L Ashare, E Paul Wileyto, Erin Logue-Chamberlain

Pageof 2

Frequent Collaborators

2 joint publications

Rebecca L Ashare

2 joint publications

Stephen J Bagley

2 joint publications

Ali Nabavizadeh

1 joint publications

Cheyenne Allenby